Latest articles

EU PERSPECTIVES - Expand, scrap, or keep it as it is? It depends on who you ask. A proposed extension of market protection for selected biotech medicines is dividing Brussels: industry is pushing for a wider scope, some MEPs want it removed entirely, while the European Commission is defending its current design. Read more

EURACTIV - The Biotech Act can help create a new confidence, proving that Europe wants to remain competitive in biotechnology, says Belgian life sciences leader Frédéric Druck. Read more

EUROPEAN BIOTECHNOLOGY MAGAZINE - The COVID-19 pandemic transformed RNA technologies into one of the most visible scientific breakthroughs of the decade. mRNA vaccines demonstrated unprecedented speed of development, large-scale manufacturing capability and global deployment, pushing RNA therapeutics into the public spotlight. But according to...

EU PERSPECTIVES - When it comes to cancer medicines, the EU should look beyond a purely 'Made in Europe' approach and embrace 'Made with Europe', according to Giancarlo Benelli, Head of Europe at BeOne Medicines. "Cancer does not have borders," he says, as many European patients still wait too long for innovative treatments. He argues that...